265 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
SC 13G/A
CVI Investments, Inc.
14 Feb 24
Galmed Pharmaceuticals / CVI Investments ownership change
2:14pm
SC 13G/A
Biotechnology Value Fund L P
14 Feb 24
Galmed Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
9:52am
SC 13G/A
GLMD
Galmed Pharmaceuticals Ltd
12 Feb 24
Galmed Pharmaceuticals / Baharaff Allen ownership change
4:15pm
EFFECT
GLMD
Galmed Pharmaceuticals Ltd
30 Nov 23
Notice of effectiveness
12:15am
POS AM
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Prospectus update (post-effective amendment)
4:48pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Current report (foreign)
4:05pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
POS AM
GLMD
Galmed Pharmaceuticals Ltd
1 Nov 23
Prospectus update (post-effective amendment)
4:15pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
GLMD
Galmed Pharmaceuticals Ltd
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
GLMD
Galmed Pharmaceuticals Ltd
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
GLMD
Galmed Pharmaceuticals Ltd
20 Sep 23
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
13 Sep 23
Current report (foreign)
4:01pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
9 Aug 23
Current report (foreign)
4:43pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
9 Aug 23
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
2 Aug 23
Consolidated Financial Statements
4:30pm
SC 13G
GLMD
Galmed Pharmaceuticals Ltd
21 Jul 23
Galmed Pharmaceuticals / CVI Investments ownership change
10:12am